Cronos Total Stockholder Equity from 2010 to 2024
| CRON Stock | USD 2.08 0.03 1.46% |
Total Stockholder Equity | First Reported 2014-06-30 | Previous Quarter 1.1 B | Current Value 1.1 B | Quarterly Volatility 678.8 M |
Check Cronos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cronos' main balance sheet or income statement drivers, such as Interest Expense of 27.2 M, Total Revenue of 93.3 M or Gross Profit of 7.3 M, as well as many indicators such as Price To Sales Ratio of 8.66, Dividend Yield of 0.0 or PTB Ratio of 0.69. Cronos financial statements analysis is a perfect complement when working with Cronos Valuation or Volatility modules.
Cronos | Total Stockholder Equity |
Latest Cronos' Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Cronos Group over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Cronos' Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cronos' overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Cronos Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 536,121,078 | |
| Geometric Mean | 51,265,523 | |
| Coefficient Of Variation | 127.57 | |
| Mean Deviation | 607,472,906 | |
| Median | 68,682,306 | |
| Standard Deviation | 683,944,614 | |
| Sample Variance | 467780.2T | |
| Range | 1.7B | |
| R-Value | 0.74 | |
| Mean Square Error | 231426.3T | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | 112,446,514 | |
| Total Sum of Squares | 6548923.3T |
Cronos Total Stockholder Equity History
About Cronos Financial Statements
Cronos investors utilize fundamental indicators, such as Total Stockholder Equity, to predict how Cronos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 1.1 B | 730.8 M |
Pair Trading with Cronos
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cronos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will appreciate offsetting losses from the drop in the long position's value.Moving together with Cronos Stock
Moving against Cronos Stock
| 0.58 | GILD | Gilead Sciences | PairCorr |
| 0.57 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.43 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.31 | VRDN | Viridian Therapeutics | PairCorr |
The ability to find closely correlated positions to Cronos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cronos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cronos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cronos Group to buy it.
The correlation of Cronos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cronos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cronos Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cronos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cronos Correlation against competitors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.144 | Earnings Share (0.12) | Revenue Per Share 0.267 | Quarterly Revenue Growth 0.46 | Return On Assets (0.04) |
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.